Brief: Ampio Pharmaceuticals Provides Regulatory Update

Ampio Pharmaceuticals

29/04/2019 14:42

April 29 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO PHARMACEUTICALS PROVIDES REGULATORY UPDATE
    * AMPIO PHARMACEUTICALS - HAS RECEIVED COMMENTS FROM U.S.
FOOD AND
DRUG ADMINISTRATION REGARDING THEIR SPECIAL PROTOCOL ASSESSMENT
    * AMPIO - FDA RECOMMENDED COMPANY NOT START THEIR
CONFIRMATORY
TRIAL WITHOUT OBTAINING FDA CONCURRENCE ON TRIAL DESIGN
    * AMPIO - CO AGREED WITH COMMENTS RECEIVED FROM FDA AND
IMMEDIATELY SENT A REVISED SPA TO FDA FOR REVIEW
    * AMPIO - HOPE TO START TRIAL IN MAY

Source text for Eikon:  ID:nPn9KtqVla 
Further company coverage:  AMPE.A 

 ((Briefs@thomsonreuters.com;))